12.56↑0.38 (3.12%)
04:01 PM,11th Dec 2023BSE : 524414
NSE :
Sector : Health care
ISIN Code : INE744C01029
Last Updated: Dec 11 2023 | 04:01 PM IST
Market Cap (₹ Cr) | 0 |
Turnover (₹ Cr) | 0.00 |
Volume (Shares) | |
Face Value | 10 |
52-WK High | 0.00 |
52-WK High Date | Invalid date |
52-WK Low | 0.00 |
52-WK Low Date | Invalid date |
All Time High | 0.00 |
All Time High Date | Invalid date |
All Time Low | 0.00 |
All Time Low Date | Invalid date |
Norris Medicines Ltd was established in September 1990 as a small scale unit at GIDC Estate Ankleshwar to manufacture non sterile dosage e.g. tablets capsules Liquid Orals Copical ointments. The Company was subsequently converted into Public Limited Company on 7th March 1992. The unit expanded to manufacture Sterile dosage in form of Ampoules & Vials. The Company got into the business in the year 1990. Commercial production of the formulation unit commenced in Nov.'91. The project commence in March 1992. Thereafter the Company came out with a Public Issue aggregating Rs 5 cr in Dec.'93 to expand its existing capacity for tablets capsules etc besides diversifying into bulk drugs and setting up an injectables unit. The project costing Rs 14.21 Crore was financed through loans and equity which got completed in 1995.In 2006 the Company launched Diabetic & Cardiac products; launched Dental product in 2007; launched New Molecule Tolperisone with Paracetamol tablet in 2012; in 2013 it extended Anti malarial range with Artemether Lumefantrine tablet & dry syrup. During the year 2013-14 the Company undertook the upgradation of Sterile Injectable Plant. The Company is one of the leading Indian manufacturers of Injections and Medicinal formulations. The Company is engaged into Health Care Industry and has 2 plants situated at GIDC Ankleshwar Gujarat. Both plants of the Company are WHO cGMP approved. At present it has renovated the Sterile Injectable Plant which is as per international standards.
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 12 |
EPS - TTM (₹) [S] | 0.00 |
P/E Ratio (X) [S] | -0.93 |
Face Value (₹) | 10 |
Latest Dividend (%) | - |
Latest Dividend Date | - |
Dividend Yield (%) | - |
Book Value Share (₹) [S] | -13.46 |
P/B Ratio (₹) [S] | -0.93 |
[*C] Consolidated [*S] Standalone |
Scheme Name ↑↓ | Amount Invested ( ₹ Cr ) ↑↓ | No Of Shares ↑↓ | Net Asset (%) ↑↓ |
---|
Date↑↓ | Broker↑↓ | Action↑↓ | Prices(Rs)↑↓ | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High | 11.50 12.76 |
Week Low/High | 11.36 13.00 |
Month Low/High | 10.75 15.00 |
Year Low/High | 10.00 16.00 |
All time Low/High | 0.60 37.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | -3.24% | % | 1.54 | 1.50% |
1 Month | 6.44% | % | 7.74 | 8.09% |
3 Month | 10.18% | % | 4.17 | 5.00% |
6 Month | 4.75% | % | 11.26 | 12.68% |
1 Year | -4.12% | % | 12.46 | 13.52% |
3 Year | 107.60% | % | 51.69 | 55.37% |
Managing Director : Vimal D Shah
Independent Director : Hiten Parikh
Independent Director : S A M Azmathullah
Independent Director : Susmita Mahapatra
Registered Office: Plot No 801/P & 802, GIDC Industrial Estate,Ankleshwar,Gujarat-393002 Ph: 91-2646-223462/227530